A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder

Translational Psychiatry

Volumn 5, Issue , 2015, Pages

  Munkholm, K ^a   Peijs, L ^a   Vinberg, M ^a   Kessing, L V ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR; BIOLOGICAL MARKER; DNA DIRECTED DNA POLYMERASE; DNA GLYCOSYLTRANSFERASE; NDUFV2 PROTEIN, HUMAN; OXOGUANINE GLYCOSYLASE 1, HUMAN; POLG PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSCRIPTOME;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DNA REPAIR; DOWN REGULATION; DSM-IV; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYPOMANIA; MALE; MANIA; NDUFV2 GENE; OGG1 GENE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLG GENE; RAPID CYCLING BIPOLAR DISORDER; SEX DIFFERENCE; UPREGULATION; YOUNG MANIA RATING SCALE; BLOOD; CASE CONTROL STUDY; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIOMARKERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA-DIRECTED DNA POLYMERASE; FEMALE; HUMANS; MALE; NADH DEHYDROGENASE; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84938590867     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.110     Document Type: Article

References (74)

1. Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. Lancet 2013; 381: 1663-1671.
2. Davis J, Maes M, Andreazza A, McGrath JJ, Tye SJ, Berk M. Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass. Mol Psychiatry 2015; 20: 152-153.
3. Goldstein BI, Young LT. Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep 2013; 15: 425.
4. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 2005; 136B: 12-25.
5. Munkholm K, Vinberg M, Berk M, Kessing LV. State-related alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disord 2012; 14: 684-696.
6. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009; 14: 156-174.
7. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 2008; 65: 395-407.
8. Kato T, Hayashi-Takagi A, Toyota T, Yoshikawa T, Iwamoto K. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet 2011; 56: 779-783.
9. Iwamoto K, Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006; 12: 349-361.
10. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, Ortmann WA et al. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 2004; 5: 347-353.
11. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neu-ropsychiatr Genet 2005; 133B: 1-5.
12. Witt SH, Juraeva D, Sticht C, Strohmaier J, Meier S, Treutlein J et al. Investigation of manic and euthymic episodes identifies state-and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder. Transl Psychiatry 2014; 4: e426.
13. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
14. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD et al. The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005; 88: 217-233.
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
16. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
17. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
18. Le-Niculescu H, Patel SD, Bhat M, Kuczenski R, Faraone SV, Tsuang MT et al. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet 2009; 150b: 155-181.
19. Kazuno AA, Ohtawa K, Otsuki K, Usui M, Sugawara H, Okazaki Y et al. Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study. PLoS One 2013; 8: e53855.
20. Washizuka S, Iwamoto K, Kakiuchi C, Bundo M, Kato T. Expression of mitochon-drial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res 2009; 63: 199-204.
21. Munkholm K, Poulsen HE, Kessing LV, Vinberg M. Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder. Bipolar Disord 2014; 17: 257-268.
22. Kubota-Sakashita M, Iwamoto K, Bundo M, Kato T. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia. Mol Brain 2014; 7: 5.
23. Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, Richards KR et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 2011; 36: 1397-1411.
24. Li X, Jope RS. Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 2010; 35: 2143-2154.
25. Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011; 7: 715-726.
26. Frey BN, Dias RS. Sex hormones and biomarkers of neuroprotection and neuro-degeneration: implications for female reproductive events in bipolar disorder. Bipolar Disord 2014; 16: 48-57.
27. Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA et al. Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS One 2009; 4: e5196.
28. Fuste M, Pinacho R, Melendez-Perez I, Villalmanzo N, Villalta-Gil V, Haro JM et al. Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis. J Psychiatr Res 2013; 47: 1608-1614.
29. Digney A, Keriakous D, Scarr E, Thomas E, Dean B. Differential changes in apoli-poprotein E in schizophrenia and bipolar I disorder. Biol Psychiatry 2005; 57: 711-715.
30. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278: 1349-1356.
31. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300-1311.
32. Munkholm K, Peijs L, Kessing LV, Vinberg M. Reduced mRNA Expression of PTGDS in Peripheral Blood Mononuclear Cells of Rapid-Cycling Bipolar Disorder Patients Compared with Healthy Control Subjects. Int J Neuropsychopharmacol 2014; 18: pyu101.
33. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004; 64: 5245-5250.
34. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008; 3: 1101-1108.
35. West SG, Ryu E, Kwok OM, Cham H. Multilevel modeling: current and future applications in personality research. J Pers 2011; 79: 2-50.
36. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000; 45: 23-41.
37. Hayden SR, Brown MD. Likelihood ratio: A powerful tool for incorporating the results of a diagnostic test into clinical decisionmaking. Ann Emerg Med 1999; 33: 575-580.
38. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-1293.
39. Sampath H. Oxidative DNA damage in disease-insights gained from base excision repair glycosylase-deficient mouse models. Environ Mol Mutagen 2014; 55: 689-703.
40. Sheng Z, Oka S, Tsuchimoto D, Abolhassani N, Nomaru H, Sakumi K et al. 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J Clin Invest 2012; 122: 4344-4361.
41. Borghini A, Cervelli T, Galli A, Andreassi MG. DNA modifications in atherosclerosis: from the past to the future. Atherosclerosis 2013; 230: 202-209.
42. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol 2011; 164: 899-904.
43. Hewitt G, Jurk D, Marques FDM, Correia-Melo C, Hardy T, Gackowska A et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012; 3: 708.
44. Kessing LV, Vradi E, Andersen PK. Life expectancy in bipolar disorder. Bipolar Disord advance online publication, 4 April 2015; doi:10.1111/bdi.12296.
45. Loft S, Danielsen P, Løhr M, Jantzen K, Hemmingsen JG, Roursgaard M et al. Urinary excretion of 8-oxo-7, 8-dihydroguanine as biomarker of oxidative damage to DNA. Arch Biochem Biophys 2012; 518: 142-150.
46. Schapira AHV. Mitochondrial diseases. Lancet 2012; 379: 1825-1834.
47. Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry 2006; 11: 577-593, 523.
48. Sitarz KS, Elliott HR, Karaman BS, Relton C, Chinnery PF, Horvath R. Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts. Mol Genet Metab 2014; 112: 57-63.
49. Kato T. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 2008; 44: 92-102.
50. Anglin RES, Mazurek MF, Tarnopolsky MA, Rosebush PI. The mitochondrial genome and psychiatric illness. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 749-759.
51. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al. Mito-chondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481-484.
52. Golob MJ, Tian L, Wang Z, Zimmerman TA, Caneba CA, Hacker TA et al. Mitochondria DNA mutations cause sex-dependent development of hypertension and alterations in cardiovascular function. J Biomech 2015; 48: 405-412.
53. Elvsashagen T, Vera E, Boen E, Bratlie J, Andreassen OA, Josefsen D et al. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord 2011; 135: 43-50.
54. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009; 11: 657-662.
55. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr. et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73: 49-62.
56. Washizuka S, Iwamoto K, Kazuno AA, Kakiuchi C, Mori K, Kametani M et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 2004; 56: 483-489.
57. Washizuka S, Kakiuchi C, Mori K, Kunugi H, Tajima O, Akiyama T et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2003; 120B: 72-78.
58. Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet 2006; 15: 1949-1962.
59. Xu C, Li PP, Kennedy JL, Green M, Hughes B, Cooke RG et al. Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. Bipolar Disord 2008; 10: 105-110.
60. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010; 60: 70-98.
61. Wong CK, Fedorak RN, Prosser CI, Stewart ME, van Zanten SV, Sadowski DC. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis 2012; 27: 1657-1664.
62. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611-622.
63. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29: 311-324.
64. Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ. All the world/'s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry 2015; 20: 23-31.
65. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 559-576.
66. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006; 147: 126-132.
67. Iwamoto K, Ueda J, Bundo M, Kojima T, Kato T. Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders. Neurosci Res 2011; 70: 238-242.
68. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 261-268.
69. Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A et al. The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement 2014; 10: 115-131.
70. Ang CS, Nice EC. Targeted in-gel MRM: a hypothesis driven approach for colo-rectal cancer biomarker discovery in human feces. J Proteome Res 2010; 9: 4346-4355.
71. Herder C, Karakas M, Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011; 90: 52-66.
72. Veenstra TD. Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies. Expert Rev Proteomics 2011; 8: 139-141.
73. Azuaje FJ, Dewey FE, Brutsaert DL, Devaux Y, Ashley EA, Wagner DR. Systems-based approaches to cardiovascular biomarker discovery. Circ Cardiovasc Genet 2012; 5: 360-367.
74. McDermott JE, Wang J, Mitchell H, Webb-Robertson BJ, Hafen R, Ramey J et al. Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data. Expert Opin Med Diagn 2013; 7: 37-51.